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and Tadashi Terui2
The epidermis is an active site of lipid metabolism, and the synthesis of fatty acids and cholesterol is required
for cutaneous homeostasis. Liver X receptor-a (LXRa) and LXRb are nuclear receptors that are activated by
oxysterols and regulate cholesterol and fatty acid metabolism. LXRs, predominantly LXRb, have been shown to
be involved in keratinocyte differentiation and epidermal permeability barrier function. Although LXR regulates
hepatic lipogenesis by inducing sterol-regulatory element-binding protein-1c (SREBP-1c), SREBP-1c induction by
LXR in the epidermis has not been studied. In this study, we report that SREBP-1c mRNA increased during
differentiation of human keratinocyte HaCaT cells and that LXR agonist effectively induced expression of LXR
target genes, including SREBP-1c and ATP-binding cassette transporter A1, in differentiated HaCaT cells.
Differentiation-associated and LXR-enhanced expression of SREBP-1c was also observed in malignant human
keratinocyte A431 cells and primary human keratinocytes. A synthetic LXR antagonist inhibited confluency-
dependent expression of SREBP-1c. Thus, SREBP-1c expression increases during keratinocyte differentiation,
and LXR activation enhances its expression.
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INTRODUCTION
The epidermis functions as a permeability barrier to prevent
the loss of water and electrolytes and the entry of toxic
compounds. The permeability barrier comprises extracellular
lipid-enriched membranes in the stratum corneum that
contain fatty acids, cholesterol, and ceramides (Feingold,
2007). Their precursor lipids, such as phospholipids, choles-
terol sulfate, glucosylceramides, and sphingomyelins, are
delivered to the extracellular space by the secretion of
lamellar bodies and metabolized at the boundary between
the stratum granulosum and the stratum corneum by enzymes
that are cosecreted in lamellar bodies (Uchida and Holleran,
2008). The lipids contained in the lamellar bodies are derived
from epidermal lipid synthesis and extracutaneous sources
such as diet (Feingold, 2007). Although the lamellar bodies
are not present in the undifferentiated basal layer of the
epidermis, they appear in the upper stratum spinosum layer
and are accumulated along with keratinocyte differentiation.
Sterol-regulatory element-binding proteins (SREBPs) are
transcription factors that regulate the expression of enzymes
involved in cholesterol and fatty acid synthesis (Goldstein
et al., 2006). SREBP-1a and 1c are the protein products of a
single gene with different promoters and alternatively spliced
transcripts. SREBP-2, a gene product distinct from SREBP-1, is
primarily involved in stimulating cholesterol synthesis,
whereas SREBP-1c induces fatty acid synthesis. SREBP-2
was reported to regulate cholesterol and fatty acid synthesis
as the predominant form in keratinocytes (Harris et al., 1998).
The increase in lipid synthesis induced by keratinocyte
differentiation appears to be due to activation of SREBPs.
The nuclear receptors liver X receptor-a (LXRa) and LXRb
play a role in lipid metabolism (Makishima, 2005). LXRa and
LXRb are expressed in murine and human keratinocytes
(Hanley et al., 2000; Komuves et al., 2002). LXR activators
stimulate keratinocyte differentiation and the formation of the
cornified envelope in an LXRb-dependent manner. LXR
activation also stimulates epidermal lipid synthesis, lamellar
body secretion, and lipid processing in the stratum corneum
(Man et al., 2005). Thus, LXRs regulate a variety of skin
functions, including lipid metabolism and permeability
barrier function. SREBP-1c is a direct target gene of LXRs,
and administration of synthetic LXR agonists in mice
increases liver and plasma triglycerides and phospholipids
through SREBP-1c-dependent induction of hepatic lipogenic
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sterol-regulatory element-binding protein
genes (Schultz et al., 2000; Liang et al., 2002). These
findings suggest that the LXR-SREBP-1c cascade plays a role
in lipid metabolism in keratinocytes. In this study, we
examined the effects of LXR ligand administration on the
expression of genes involved in lipid metabolism in
keratinocytes.
RESULTS
Confluency-dependent expression of lipid metabolism genes
As the spontaneously immortalized keratinocyte cell line
HaCaT retains differentiation potential in vivo and in vitro,
we utilized these cells to examine the effects of an LXR ligand
on induction of genes involved in lipid metabolism
(Ryle et al., 1989). When HaCaT cells were plated at a
concentration of 1 105 cells per well on a six-well plate
(9.6 cm2 per well), the cells proliferated until they became
confluent on day 7 (Figure 1a and b). A time-dependent
increase in the expression of involucrin, a keratinocyte
differentiation marker, was observed. Involucrin induction
may be due to density-dependent differentiation of HaCaT
cells (Ryle et al., 1989). T0901317 (N-(2,2,2-trifluoroethyl)-
N-[4–(2,2,2-trifluoro-1-hydroxy-1-trifluoromethylethyl)phenyl]
benzenesulfonamide) is a potent and selective agonist for
both LXRa and LXRb (Schultz et al., 2000). We treated cells
with T0901317 (Figure 1c) and examined the expression of
LXR target genes. Interestingly, the expression of SREBP-1c,
an LXR target that plays a role in fatty acid synthesis, was
enhanced in cells treated with T0901317 with increasing
cellular confluency (Figure 1d). SREBP-1c expression was
also increased in confluent cells in the absence of ligand.
T0901317 treatment induced the expression of another LXR
target gene, ATP-binding cassette transporter A1 (ABCA1),
more effectively in confluent cells than in non-confluent
cells. Expression of SREBP-1c and ABCA1 was not further
increased at day 9. This may be due to decreased cell
viability (Figure 1b). Expression of fatty acid synthase (FAS), a
target of both SREBP-1 and LXRs (Joseph et al., 2002), was
slightly increased in confluent cells without LXR ligand, and
T0901317 treatment was not effective on FAS induction. The
mRNA levels of LXRa and LXRb were slightly increased in
confluent cells and were unaffected by T0901317 treat-
ment. Thus, the induction of SREBP-1c and ABCA1 mRNA
expression by LXR ligand was enhanced by the duration of
cell culture, and enhanced expression may be associated
with confluency-dependent differentiation of HaCaT cells.
We examined protein expression of SREBP-1 and LXRs by
immunoblotting. As SREBP-1 proteins undergo rapid degra-
dation (Wang et al., 1994), we could not detect SREBP-1
proteins without treating the cells with a protease inhibitor
(data not shown). Then, we treated the cells with an inhibitor
of neutral cysteine proteases and examined SREBP-1 protein
expression in nuclear extracts. SREBP-1c protein levels are
increased from day 1 to day 3 in HaCaT cells, and T0901317
treatment increased SREBP-1 proteins in both precursor and
mature forms at day 3 and day 7 (Figure 1e). There was no
increase in SREBP-1 expression in T0901317-treated cells
from day 3 to day 7. LXRb protein was observed in HaCaT
cells, but LXRa was not detected.
Density-dependent differentiation and enhanced expression
of lipogenic genes
To examine the correlation between density-dependent
differentiation and enhanced expression of LXR target genes,
we plated HaCaT cells at a low density (1 105 cells per
well) and at a high density (4105 cells per well) in six-well
plates, cultured them for 1 day, and then treated them with
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Figure 1. Confluency-dependent induction of LXR target genes in HaCaT
cells. (a) HaCaT cells proliferate until reaching confluency at day 7.
Bar¼50 mm. (b) Cell number reaches maximum at day 7. (c) Experimental
procedure for T0901317 treatment in cells of different confluency. HaCaT
cells were treated with vehicle control or T0901317 (1 mM) at day 2, 4, 6, or 8;
cultured for 24 hours; and harvested for examination of mRNA (d) and protein
expression (e). (d) mRNA expression of SREBP-1c, ABCA1, FAS, involucrin,
LXRa, and LXRb. *Po0.05; **Po0.01. (e) Nuclear expression of SREBP-1,
LXRb, and lamin B. Western blotting was repeated twice with similar results.
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T0901317 (Figure 2a). Increased expression of the keratino-
cyte differentiation markers involucrin and transglutaminase
1 was observed in cells cultured at a high density (Figure 2b).
Without T0901317 treatment, expression of SREBP-1c and
another lipogenic gene, stearyl CoA desaturase-1 (SCD-1),
which is a SREBP-1c and LXR target (Chu et al., 2006), was
increased in high-density culture. T0901317-induced expres-
sion of these genes was enhanced in high-density cells.
Expression of ABCA1 and FAS did not change between high-
density culture and low-density culture in the absence of LXR
ligand, and T0901317 increased gene expression in a
density-independent manner. The expression of acetyl CoA
carboxylase was slightly induced by T0901317 and there was
no density-dependent enhancement. The expression of a
cholesterol metabolism regulator (SREBP-2) and cholesterol
synthetic enzymes (3-hydroxy-3-methylglutaryl coenzyme A
(HMG-CoA) synthase and HMG-CoA reductase) was not
affected by cell density or T0901317 treatment. LXRa and
LXRb expression did not differ in high-density culture and
low-density culture. Therefore, increased expression of
SREBP-1c and SCD-1 and enhanced induction of these genes
by LXR activation were associated with density-dependent
differentiation.
Differentiation-dependent but cell contact-independent
induction of SREBP-1c
Confluent cells exhibit increased intercellular adhesion, and
the cell–cell adhesion interaction induces various cellular
responses (Mu¨ller et al., 2008). To discriminate between
effects of cellular differentiation and differentiation-indepen-
dent effects in confluency-dependent induction of SREBP-1c,
we utilized a suspension culture of HaCaT cells. Keratino-
cytes cultured in suspension, in which the cell–matrix
attachment is disrupted, undergo terminal differentiation
(Watt et al., 1988). We cultured HaCaT cells in a plate
coated with poly(2-hydroxyethyl methacrylate) to inhibit
cell–matrix attachment and examined the expression
of involucrin and SREBP-1c. In suspension culture, the
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Figure 2. Density-dependent expression of genes involved in lipid metabolism in HaCaT cells. (a) Experimental procedure for T0901317 treatment in
HaCaT cells cultured at low density or high density. HaCaT cells were plated at 1 105 cells per well or at 4 105 cells per well in a 9.6 cm2 per well plate and
treated with vehicle control or 1 mM T0901317 for 24 hours. (b) mRNA expression of keratinocyte differentiation markers (involucrin and transglutaminase 1),
genes involved in lipid metabolism (SREBP-1c, SCD-1, ABCA1, FAS, acetyl CoA carboxylase (ACC), SREBP-2, HMG-CoA synthase, HMG-CoA reductase),
and LXRs. *Po0.05; **Po0.01.
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differentiation marker involucrin was strongly induced and
the expression of SREBP-1c was also enhanced (Figure 3a).
T0901317 treatment further increased SREBP-1c expression
in HaCaT cells cultured in a suspension (Figure 3b). Thus, the
induction of SREBP-1c mRNA expression is associated with
cellular differentiation.
Expression of SREBP-1c in malignant keratinocytes and
primary keratinocytes
To examine whether confluency-dependent induction of
SREBP-1c is observed in malignant keratinocytes and primary
keratinocytes, we cultured epidermoid carcinoma A431 cells
and normal human epidermal keratinocytes (NHEK) in the
absence or presence of T0901317. A431 cells grew until they
became confluent at day 11 (Figure 4a). Expression of
involucrin was increased at day 5 and was unaffected by
continuous culture (Figure 4b). Expression of SREBP-1c, FAS,
and ABCA1 increased slightly from day 5. T0901317 treatment
minimally decreased the involucrin expression in A431 cells,
and it effectively induced SREBP-1c, FAS, and ABCA1 in
involucrin-expressing cells. Thus, the expression of SREBP-1c,
FAS, and ABCA1 and their induction by LXR are associated
with differentiation of A431 cells. Microscopic observations
showed that primary keratinocyte NHEK stopped proliferation
before they became confluent (data not shown), and NHEK
increased involucrin expression at day 5 (Figure 5a). A time-
dependent increase in the SREBP-1c expression was also
observed in NHEK. As in HaCaT cells, high-density culture of
NHEK increased the expression of involucrin and SREBP-1c but
not of ABCA1 (Figure 5b). T0901317 increased SREBP-1c
expression in both low-density culture and high-density
culture. T0901317 increased ABCA1 expression in a density-
independent manner. Although differentiation mechanisms
may differ in NHEK, HaCaT, and A431 cells, differentiated
cells enhance SREBP-1c mRNA expression through LXR
activation.
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Figure 3. Differentiation of HaCaT cells in suspension culture increases
expression of SREBP-1c. (a) mRNA expression of involucrin and SREBP-1c
in a regular plate (non-coated) and in a poly(2-hydroxyethyl methacrylate)-
coated plate for suspension (coated) for 1 (D1), 2 (D2), or 3 days (D3).
(b) Effect of T0901317 on SREBP-1c expression in HaCaT cells in suspension
culture. HaCaT cells were cultured in suspension for 3 days and treated with
vehicle control or 1 mM T0901317 for 24 hours. *Po0.05; **Po0.01.
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Figure 4. Differentiation-associated expression of LXR target genes in
epidermoid carcinoma A431 cells. (a) Number of A431 cells. A431
carcinoma cells proliferated until day 11. (b) mRNA expression of involucrin,
SREBP-1c, FAS, and ABCA1 in A431 cells. Cells were cultured, treated with
vehicle control or 1 mM T0901317 for 24 hours, and harvested at the indicated
day as shown in Figure 1c. *Po0.05; **Po0.01.
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Suppression of SREBP-1c expression by an LXR antagonist
5CPPSS-50 (5-chloro-N-20-n-pentylphenyl-1,3-dithiophthali-
mide) is an LXR antagonist with IC50 values of 10 and 13mM
for LXRa and LXRb, respectively (Noguchi-Yachide et al.,
2007). 5CPPSS-50 (10 mM) did not inhibit ligand-dependent
activation of peroxisome proliferator-activated receptor-a
(PPARa) or PPARg in transfection experiments (data not
shown). We examined the effect of 5CPPSS-50 on SREBP-1c
expression in HaCaT cells. Confluent HaCaT cells were
treated with 5CPPSS-50 (10mM) with or without T0901317
(0.3mM) (Figure 6a). Treatment with 5CPPSS-50 suppressed
confluency-dependent expression of ABCA1 and SREBP-1c
(Figure 6b), suggesting that their mRNA expression is
mediated by endogenous ligand-dependent LXR activation.
T0901317 addition increased the ABCA1 and SREBP-1
expression suppressed by 5CPPSS-50. These data suggest that
a ligand-dependent mechanism is involved in the increased
expression of SREBP-1c in differentiated keratinocytes.
DISCUSSION
In this study, we investigated the expression of LXR target genes
in keratinocytes and found exogenous ligand-dependent and -
independent induction of LXR target genes in differentiated
keratinocytes. SREBP-1c plays an important role in hepatic
lipogenesis (Goldstein et al., 2006). LXR agonists stimulate
hepatic lipogenesis through SREBP-1c-dependent induction of
lipogenic genes (Schultz et al., 2000; Liang et al., 2002). In the
epidermis, LXR agonists also stimulate fatty acid synthesis, and
topical treatment with LXR agonists enhances permeability
barrier function (Komuves et al., 2002; Feingold, 2007). These
findings suggest that the LXR-SREBP-1c cascade plays a role in
lipogenic gene induction in the epidermis. However, SREBP-1
was reported to be absent from the epidermis, and SREBP-2 has
been proposed to induce both fatty acid and cholesterol
synthesis (Harris et al., 1998). As LXR induces expression of
SREBP-1c but not of SREBP-1a or SREBP-2 (Repa et al., 2000;
Schultz et al., 2000), LXR-dependent stimulation of lipogenesis
in the epidermis would be expected to be mediated by SREBP-
1c. We detected SREBP-1c mRNA and protein in HaCaT cells,
and T0901317 increased SREBP-1c expression. Harrison et al.
(2007) reported that SREBP-1 is expressed in keratinocytes as
well as in sebocytes. Thus, SREBP-1c is induced by LXR
activation and is suggested to play a role in lipogenic gene
regulation in keratinocytes.
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Figure 6. Effect of LXR antagonist on expression of SREBP-1c in HaCaT cells.
(a) Experimental procedure for treatment with LXR agonist and antagonist in
HaCaT cells. Cells were cultured for 6 days and treated with vehicle control
or 10 mM 5CPPSS-50 in the absence or presence of 0.3 mM T0901317 for
24 hours. (b) Effect of 5CPPSS-50 on confluency-dependent expression of
ABCA1 and SREBP-1c. *Po0.05; **Po0.01.
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Liver X receptors have been shown to play an important
role in cutaneous homeostasis (Schmuth et al., 2008).
Although both LXRa and LXRb are expressed in cultured
human keratinocytes and throughout all layers of the
human epidermis (Hanley et al., 2000; Russell et al., 2007),
LXRb is the predominant isoform transcribed in mouse
epidermis (Komuves et al., 2002). LXR activators stimulate
keratinocyte differentiation in an LXRb-dependent manner
(Komuves et al., 2002). We detected LXRb and not LXRa
protein in HaCaT cells, although real-time quantitative
reverse transcription-PCR analysis showed mRNA expression
for both isoforms, a finding that supports a predominant role
for LXRb in keratinocytes. Oxysterols are in vivo ligands for
LXR in the liver (Chen et al., 2007). Although mechanisms of
oxysterol metabolism in the epidermis have not been
elucidated, increased oxysterol production may activate
LXR and induce SREBP-1c expression in differentiated
keratinocytes. LXRs are common inducers of SREBP-1 and
ABCA1 gene expression (Makishima, 2005), and administra-
tion of an LXR antagonist decreased their expression in
confluent cells. These cells are suggested to contain
increased endogenous LXR ligands, such as oxysterols,
although the possibility that 5CPPSS-50 has LXR-independent
effects cannot be ruled out. We need to develop more potent
antagonists to elucidate the role of endogenous ligand-
dependent activation of LXRs in keratinocytes. LXRa and
LXRb exhibit ligand-independent activation by interacting
with other proteins, such as retinoid X receptor and
coactivators (Wiebel et al., 1999; Son et al., 2008).
Expression of coactivator proteins changes during keratino-
cyte differentiation (Oda et al., 2003). Although LXRs are
necessary factors for SREBP-1c expression, several mechan-
isms, including insulin signaling, regulate SREBP-1c expres-
sion (Tobin et al., 2002). LXR ligand-independent
mechanisms may also be involved in SREBP-1c mRNA
expression. PPARs are expressed in the epidermis (Schmuth
et al., 2008), and activation of PPARs, especially PPARd,
stimulates keratinocyte differentiation (Westergaard et al.,
2001). However, PPARa activation suppresses LXR-depen-
dent induction of the SREBP-1c gene in hepatocytes (Ide
et al., 2003). PPARs may not be involved in mRNA
expression of SREBP-1c in keratinocytes. Nuclear SREBP-1c
protein expression was increased from day 1 to day 3 in
HaCaT cells, and T0901317 treatment increased SREBP-1
proteins in both precursor and mature forms. However, a
differentiation-associated increase in SREBP-1 proteins was
not observed in T0901317-treated cells. SREBP-1 protein levels
are regulated by multiple mechanisms, such as synthesis,
proteolytic processing, translocation, and degradation (Gold-
stein et al., 2006). PPARd inhibits the proteolytic processing of
SREBP-1 through the induction of insulin-induced gene-1 in
hepatocytes (Qin et al., 2008). Differentiation-associated
expression of SREBP-1 proteins may be regulated by mRNA
expression and additional mechanisms. Further studies are
required to elucidate differentiation-associated induction of
SREBP-1c. Taken together, these studies show that basal mRNA
expression of SREBP-1c increases during keratinocyte differ-
entiation, and the LXR agonist further enhances its expression.
LXR ligands should prove to be useful agents in stimulating
epidermal lipogenic activity.
MATERIALS AND METHODS
Chemical compounds
T0901317 was purchased from Cayman Chemical (Ann Arbor, MI),
and 5CPPSS-50 was synthesized in our laboratory (Noguchi-Yachide
et al., 2007).
Cell culture
The human immortalized keratinocyte cell line HaCaT (Boukamp
et al., 1988) and epidermoid carcinoma cell line A431 (Giard et al.,
1973) were cultured in DMEM containing 10% fetal bovine serum,
100Uml1 penicillin, and 100mgml1 streptomycin at 371C in a
humidified atmosphere containing 5% CO2. NHEK (Kurabo Indus-
tries, Osaka, Japan) were cultured in serum-free medium (Humedia-
KG2; Kurabo Industries) containing 10 mgml1 insulin, 0.1 ngml1
human recombinant epidermal growth factor, 0.5 mgml1 hydro-
cortisone, 0.4% bovine pituitary extract, 100Uml1 penicillin, and
100mgml1 streptomycin according to the manufacturer’s recom-
mendations (Komatsu et al., 2003). For suspension culture, cells
were seeded on dishes that were pre-coated with poly(2-hydro-
xyethyl methacrylate) (Sigma-Aldrich, St Louis, MO) (Watt et al.,
1988). Cells were counted in a Z1S Coulter Counter (Beckman
Coulter, Fullerton, CA).
Real-time quantitative reverse transcription-PCR analysis
Total RNAs from samples were prepared with RNAiso (Takara Bio,
Otsu, Japan), and cDNAs were synthesized using the ImProm-II
reverse transcription system (Promega, Madison, WI). Real-time
quantitative reverse transcription-PCR was performed on the ABI
PRISM 7000 sequence detection system (Applied Biosystems, Foster
City, CA) using SYBR Premix Ex Taq (Takara Bio) as described
previously (Kalaany et al., 2005; Ishizawa et al., 2008). Primer
sequences are listed in Table S1. The RNA values were normalized
to the level of glyceraldehyde-3-phosphate dehydrogenase mRNA.
Immunoblotting
Cells were treated with 25mgml1 calpain inhibitor (ALLN; EMD
Chemicals, San Diego, CA) for 2hours before harvest, and nuclear
extracts were prepared as described previously (Wang et al., 1994). The
proteins were separated by SDS-PAGE and were transferred to a
nitrocellulose membrane; probed with anti-SREBP-1 antibody (BD
Biosciences, San Jose, CA), anti-LXRb antibody (Perseus Proteomics,
Tokyo, Japan), or anti-lamin B antibody (Santa Cruz Biotechnology,
Santa Cruz, CA); and visualized with an alkaline phosphatase conjugate
substrate system (Inaba et al., 2007). The anti-SREBP-1 antibody
recognizes the N-terminal basic helix-loop-helix domain of human
SREBP-1 and is not cross-reactive with SREBP-2 (Sakai et al., 1997).
Statistics
All values are shown as means±1 SD of triplicate assays. The
unpaired two-group Student t-test was performed to assess significant
differences.
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